A Study of EDP1066 in Healthy Participants and Participants With Mild to Moderate Psoriasis and Atopic Dermatitis

NCT03542994 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

114

Enrollment

INDUSTRY

Sponsor class

Conditions

Psoriasis
Atopic Dermatitis

Interventions

OTHER: EDP1066
DRUG: Placebo oral capsule

Sponsor

Evelo Biosciences, Inc.